Palvella Therapeutics appoints Dr. James Treat as Chief Medical Officer to advance QTORIN™ and support rare skin disease therapies.

Leader in pediatric dermatology with nearly 20 years of distinguished clinical, research, and academic experience Longstanding Palvella clinical collaborator and QTORIN™ trial investigator brings deep ...

My regular checkup showed I have prediabetes. My doctor explained how to change my diet, which I understand. He also talked about exercise, and my sister says that’s ...

The global sports medicine industry is evolving by integrating Eastern modalities with Western science, aiming to enhance ...

A healthy baby girl has been born in Athens from an embryo frozen more than 22 years ago, in a remarkable medical case shaped ...

UC Davis Health's executive director of mid-revenue cycle on transforming coders into AI validators, data analysts and strategic auditors.

The conversation on artificial intelligence (AI) in healthcare has shifted. A couple of years ago, the question was, "What AI use cases might work for our ...

Six AI models picked the same "random" number. Clinical ops leaders are finally asking what that reveals about every ...

Clinical trials have become more complex, longer, and data-intensive. But the way many clinical-development decisions are ...

As AI adoption accelerates across healthcare, the conversation is increasingly shifting from AI model capabilities to broader ...

According to the latest figures from the Office of the Australian Information Commissioner (OAIC), the health sector consistently reports the highest number of data breaches, accounting for ...

Spread the loveWhen we send our kids off to school, or log into our own university portals, we rarely stop to think about the ...